PARP1 and neoplasm: Zhang et al. focused on PARP, which is highly expressed in SCLC, and showed that radiotherapy combined with PARP inhibitor and anti-PD-L1 treatment interestingly prolongs survival in mouse SCLC models and inhibits tumour growth [78].